The Triple Negative Breast Cancer Foundation (TNBCF)-AACR NextGen Grant for Transformative Cancer Research represent the AACR’s flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence.
While the research proposed for funding may be basic, translational, or clinical in nature in any area of cancer research, the 2024 TNBCF-AACR NextGen Grant will be awarded only to triple negative breast cancer-focused projects.
The grants provide $450,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, graduate students (including tuition costs), and research assistants, research/laboratory supplies, equipment, travel applicable to the research project, publication charges for manuscripts that pertain directly to the funded project, other research expenses, and indirect costs.